Difficulty: Medium
Average Score: 75%
Practice
A 58-year-old woman who is obese presents to the emergency department with diaphoresis and crushing chest pain that radiates to her left arm. The physician orders an ECG and checks her cardiac enzymes to confirm his suspicion of myocardial infarction. Because of the quick response and intervention, she survives and is ultimately discharged with a prescription for low-dose daily aspirin to inhibit platelet aggregation. Two weeks after discharge, she takes ibuprofen for a tension headache. What is the effect of the ibuprofen on her anticoagulation regimen?
Correct answer
D
Rationale
The correct answer is D) Insufficient antiplatelet activity because of inadequate platelet cyclooxygenase inhibition. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that competes with aspirin for binding to the enzyme cyclooxygenase. Aspirin irreversibly acetylates cyclooxygenase, inhibiting platelet aggregation, while ibuprofen competes reversibly, leading to reduced effectiveness of aspirin. This phenomenon is known as aspirin resistance.
Option A is incorrect because ibuprofen does not act synergistically with aspirin on platelets; instead, it competes with aspirin. Option B is incorrect as ibuprofen's effects on endothelial cells are not relevant in this context. Option C is incorrect as ibuprofen's metabolism does not significantly impact aspirin's antiplatelet effects.
This scenario underscores the importance of understanding drug interactions, especially in cardiovascular patients. Healthcare providers must educate patients to avoid NSAIDs like ibuprofen when taking aspirin for cardiovascular protection to prevent compromising the antiplatelet effects of aspirin, thereby reducing the risk of adverse cardiovascular events.
Option A is incorrect because ibuprofen does not act synergistically with aspirin on platelets; instead, it competes with aspirin. Option B is incorrect as ibuprofen's effects on endothelial cells are not relevant in this context. Option C is incorrect as ibuprofen's metabolism does not significantly impact aspirin's antiplatelet effects.
This scenario underscores the importance of understanding drug interactions, especially in cardiovascular patients. Healthcare providers must educate patients to avoid NSAIDs like ibuprofen when taking aspirin for cardiovascular protection to prevent compromising the antiplatelet effects of aspirin, thereby reducing the risk of adverse cardiovascular events.